Special Investigation in Patients With Psoriatic Arthritis (PsA) (Working Productivity and Activity Impairment [WPAI])

AbbVie

Status: Completed

Conditions: Psoriatic Arthritis

Study type: Observational

Funder types: Industry

Identifiers

NCT02414633

P15-084

Details and patient eligibility

About

A special investigation (post marketing observational study [PMOS]/non-mandatory) of HUMIRA® in Japanese psoriatic arthritis patients who are engaged in paid work.

Enrollment: 148 patients

Sex: All

Ages: 16+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Paid workers (including part-time) with Psoriatic Arthritis, who have never administered adalimumab, and are diagnosed by ClASsification of Psoriatic ARthritis (CASPAR) criteria

Exclusion criteria

• Subjects showing decreased basic activities of daily life such as hospitalization and bedridden
• Subjects with contraindications to adalimumab

Trial design

148 participants in 1 patient group

Humira

Description:

Subjects with Psoriatic Arthritis taking adalimumab under conditions of daily clinical practice.